SK379692A3 - Stable salts of (+)-(1s,2r)-2-//n-(2-hydroxylamino-2- -oxoethyl)-n-methyl-amino/carbonyl/cyclohexan-1-carboxylic acid, method of their preparation and pharmaceutical agents containing these salts - Google Patents
Stable salts of (+)-(1s,2r)-2-//n-(2-hydroxylamino-2- -oxoethyl)-n-methyl-amino/carbonyl/cyclohexan-1-carboxylic acid, method of their preparation and pharmaceutical agents containing these salts Download PDFInfo
- Publication number
- SK379692A3 SK379692A3 SK3796-92A SK379692A SK379692A3 SK 379692 A3 SK379692 A3 SK 379692A3 SK 379692 A SK379692 A SK 379692A SK 379692 A3 SK379692 A3 SK 379692A3
- Authority
- SK
- Slovakia
- Prior art keywords
- oxoethyl
- carbonyl
- salts
- group
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI913448A IT1252708B (it) | 1991-12-23 | 1991-12-23 | Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK379692A3 true SK379692A3 (en) | 1995-04-12 |
Family
ID=11361409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK3796-92A SK379692A3 (en) | 1991-12-23 | 1992-12-21 | Stable salts of (+)-(1s,2r)-2-//n-(2-hydroxylamino-2- -oxoethyl)-n-methyl-amino/carbonyl/cyclohexan-1-carboxylic acid, method of their preparation and pharmaceutical agents containing these salts |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0575572A1 (xx) |
| JP (1) | JPH06506002A (xx) |
| CN (1) | CN1079474A (xx) |
| AU (1) | AU657591B2 (xx) |
| BG (1) | BG98050A (xx) |
| BR (1) | BR9205652A (xx) |
| CA (1) | CA2104372A1 (xx) |
| CZ (1) | CZ379692A3 (xx) |
| EE (1) | EE9400006A (xx) |
| FI (1) | FI933685A (xx) |
| HR (1) | HRP921454A2 (xx) |
| HU (1) | HUT69287A (xx) |
| IT (1) | IT1252708B (xx) |
| LV (1) | LV10426B (xx) |
| MA (1) | MA22749A1 (xx) |
| MX (1) | MX9207543A (xx) |
| NZ (1) | NZ245547A (xx) |
| PL (1) | PL169086B1 (xx) |
| PT (1) | PT101156A (xx) |
| RU (1) | RU2079489C1 (xx) |
| SI (1) | SI9200409A (xx) |
| SK (1) | SK379692A3 (xx) |
| TN (1) | TNSN92117A1 (xx) |
| WO (1) | WO1993013056A1 (xx) |
| YU (1) | YU110892A (xx) |
| ZA (1) | ZA9210004B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264860B1 (it) * | 1993-06-21 | 1996-10-17 | Guidotti & C Spa Labor | Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici |
| US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| FR2817241B1 (fr) | 2000-11-30 | 2003-03-07 | Cebal | Tube aluminium avec embout secable |
| CN101516191A (zh) * | 2006-09-28 | 2009-08-26 | 默克公司 | Saha的胺碱盐和其多晶型物 |
| MX2022005016A (es) * | 2020-04-27 | 2022-05-16 | Carter Hoffmann LLC | Sistema de movimiento de puerta para gabinete. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1224627B (it) * | 1988-04-12 | 1990-10-04 | Guidotti & C Spa Labor | Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono. |
-
1991
- 1991-12-23 IT ITMI913448A patent/IT1252708B/it active IP Right Grant
-
1992
- 1992-12-12 CA CA002104372A patent/CA2104372A1/en not_active Abandoned
- 1992-12-12 HU HU9302389A patent/HUT69287A/hu unknown
- 1992-12-12 EP EP92924726A patent/EP0575572A1/en not_active Withdrawn
- 1992-12-12 JP JP5511398A patent/JPH06506002A/ja active Pending
- 1992-12-12 WO PCT/EP1992/002903 patent/WO1993013056A1/en not_active Application Discontinuation
- 1992-12-12 RU RU9293052414A patent/RU2079489C1/ru active
- 1992-12-12 AU AU30871/92A patent/AU657591B2/en not_active Ceased
- 1992-12-12 BR BR9205652A patent/BR9205652A/pt not_active Application Discontinuation
- 1992-12-21 NZ NZ245547A patent/NZ245547A/en unknown
- 1992-12-21 SK SK3796-92A patent/SK379692A3/sk unknown
- 1992-12-21 CZ CS923796A patent/CZ379692A3/cs unknown
- 1992-12-22 HR HR921454A patent/HRP921454A2/hr not_active Application Discontinuation
- 1992-12-22 MA MA23040A patent/MA22749A1/fr unknown
- 1992-12-22 SI SI9200409A patent/SI9200409A/sl unknown
- 1992-12-23 PT PT101156A patent/PT101156A/pt not_active Application Discontinuation
- 1992-12-23 PL PL92297118A patent/PL169086B1/pl unknown
- 1992-12-23 ZA ZA9210004A patent/ZA9210004B/xx unknown
- 1992-12-23 YU YU110892A patent/YU110892A/sh unknown
- 1992-12-23 TN TNTNSN92117A patent/TNSN92117A1/fr unknown
- 1992-12-23 MX MX9207543A patent/MX9207543A/es unknown
- 1992-12-23 LV LVP-92-358A patent/LV10426B/lv unknown
- 1992-12-23 CN CN92113839A patent/CN1079474A/zh active Pending
-
1993
- 1993-08-18 BG BG98050A patent/BG98050A/bg unknown
- 1993-08-20 FI FI933685A patent/FI933685A/fi not_active Application Discontinuation
-
1994
- 1994-05-23 EE EE9400006A patent/EE9400006A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9207543A (es) | 1993-08-01 |
| FI933685A0 (fi) | 1993-08-20 |
| CZ379692A3 (en) | 1993-09-15 |
| LV10426A (lv) | 1995-02-20 |
| HUT69287A (en) | 1995-09-28 |
| NZ245547A (en) | 1995-12-21 |
| CA2104372A1 (en) | 1993-06-24 |
| AU657591B2 (en) | 1995-03-16 |
| MA22749A1 (fr) | 1993-07-01 |
| YU110892A (sh) | 1996-01-08 |
| WO1993013056A1 (en) | 1993-07-08 |
| ITMI913448A0 (it) | 1991-12-23 |
| PL169086B1 (pl) | 1996-05-31 |
| PT101156A (pt) | 1994-06-30 |
| ZA9210004B (en) | 1993-12-13 |
| CN1079474A (zh) | 1993-12-15 |
| TNSN92117A1 (fr) | 1993-06-08 |
| BR9205652A (pt) | 1994-05-03 |
| IT1252708B (it) | 1995-06-26 |
| EE9400006A (et) | 1995-12-15 |
| FI933685A (fi) | 1993-08-20 |
| HU9302389D0 (en) | 1993-11-29 |
| AU3087192A (en) | 1993-07-28 |
| LV10426B (en) | 1995-08-20 |
| PL297118A1 (en) | 1993-09-06 |
| BG98050A (bg) | 1994-04-29 |
| EP0575572A1 (en) | 1993-12-29 |
| ITMI913448A1 (it) | 1993-06-23 |
| JPH06506002A (ja) | 1994-07-07 |
| RU2079489C1 (ru) | 1997-05-20 |
| HRP921454A2 (en) | 1995-02-28 |
| SI9200409A (en) | 1993-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nishizawa et al. | Synthesis and structure-activity relations of bestatin analogs, inhibitors of aminopeptidase B | |
| Szirtes et al. | Synthesis of thyrotropin-releasing hormone analogs. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity | |
| CN102946726B (zh) | 新型降血糖化合物 | |
| EP0340064A1 (fr) | Benzodiazépines, leur procédé et intermédiaires de préparation et leurs applications en thérapeutique | |
| Krogsgaard-Larsen et al. | GABA agonists. Resolution, absolute stereochemistry and enantioselectivity of (S)-(+)-and (R)-(-)-dihydromuscimol | |
| SK379692A3 (en) | Stable salts of (+)-(1s,2r)-2-//n-(2-hydroxylamino-2- -oxoethyl)-n-methyl-amino/carbonyl/cyclohexan-1-carboxylic acid, method of their preparation and pharmaceutical agents containing these salts | |
| BRPI1014070B1 (pt) | processos para a produção de inibidor de dipeptidil peptidase-iv e intermediário | |
| EP1731501A1 (en) | Method of amidocarbonylation reaction | |
| CS197268B2 (en) | Process for preparing l-pyroglutamyl-l-histidyl-3-alkylprolinamides | |
| SK13442000A3 (sk) | Postup na prípravu tetrapeptidu | |
| JPH09176115A (ja) | 光学活性なｎ−ベンジル−３−アミノピロリジンの製造方法 | |
| EP0252030B1 (en) | Derivatives of l-amino acyl l-carnitine, process for their preparation and pharmaceutical compositions having hepatoprotecting activity containing same | |
| USRE29732E (en) | Tripeptide | |
| EP1048674A1 (en) | Method for separating and purifying aspartame and aspartame derivative | |
| CN112851536B (zh) | 一种利用嘧啶类缩合剂点击构建酰胺键的方法及其在酰胺和多肽合成中的应用 | |
| US4975418A (en) | Therapeutically active compositions of pseudo-peptide of glutamyl-aspartic acid | |
| EP0101633B1 (en) | Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives | |
| CN109053771B (zh) | 一种托法替布的有关物质及其制备方法和应用 | |
| KR970002910B1 (ko) | 촉매환원 방법에 의한 아스파탐의 제조방법 | |
| Landvatter | Radiolabelled amino acids: Synthesis of NG‐mesitylenesulfonyl‐N2‐[3H] methyl‐arginine | |
| CN113980096A (zh) | 一种吨级培哚普利叔丁胺的合成工艺方法 | |
| Windridge | ANALOGS OF ANGIOTENSIN-II: THEIR SYNTHESIS AND BIOLOGICAL EVALUATION | |
| CZ20003342A3 (cs) | Způsob přípravy tetrapeptidu | |
| EP0564587A1 (en) | Solution phase process for synthesis of peptide | |
| KR20040072397A (ko) | 탐술로신의 정제 방법 |